Filing Details
- Accession Number:
- 0001225208-13-003755
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-02-12 16:03:22
- Reporting Period:
- 2013-02-11
- Filing Date:
- 2013-02-12
- Accepted Time:
- 2013-02-12 16:03:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1385187 | Covidien Plc | COV | Surgical & Medical Instruments & Apparatus (3841) | 980624794 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1400563 | J Charles Dockendorff | C/O Covidien 15 Hampshire Street Mansfield MA 02048 | Evp & Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2013-02-11 | 32,457 | $35.45 | 168,029 | No | 4 | M | Direct | |
Ordinary Shares | Disposition | 2013-02-11 | 32,457 | $63.31 | 135,572 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2013-02-11 | 32,457 | $0.00 | 32,457 | $35.45 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2014-03-25 | No | 4 | M | Direct |
Footnotes
- The price reported is a weighted average price. Shares were sold in multiple transactions at prices ranging from $63.26 to $63.37. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, full information regarding the number of shares sold at each separate price.
- Fully exercisable.